AK, H., Z, C., A, S., SW, C., SA, J., & P, S. (2012). Immunosignaturing can detect products from molecular markers in brain cancer. PloS one, 7(7), e40201. https://doi.org/10.1371/journal.pone.0040201
Chicago Style (17th ed.) CitationAK, Hughes, Cichacz Z, Scheck A, Coons SW, Johnston SA, and Stafford P. "Immunosignaturing Can Detect Products from Molecular Markers in Brain Cancer." PloS One 7, no. 7 (2012): e40201. https://doi.org/10.1371/journal.pone.0040201.
MLA (9th ed.) CitationAK, Hughes, et al. "Immunosignaturing Can Detect Products from Molecular Markers in Brain Cancer." PloS One, vol. 7, no. 7, 2012, p. e40201, https://doi.org/10.1371/journal.pone.0040201.
Warning: These citations may not always be 100% accurate.